Waters Reports 8 Percent Spike in Q4 Revenues | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported fourth-quarter 2011 results that beat analyst estimates on the top and bottom line.

For the period ended Dec. 31, the firm posted net sales of $521.4 million, up 8 percent from $483.6 million a year ago and surpassing Wall Street expectations of $516.9 million.

Organically, sales were up 8 percent for the quarter, President and CEO Douglas Berthiaum said during a conference call following the release of Waters' results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.